Literature DB >> 16004600

RITA--a small-molecule anticancer drug that targets p53.

Sheila A Doggrell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16004600     DOI： 10.1517/13543784.14.6.739

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN： 1354-3784            Impact factor:   6.206


× No keyword cloud information.
  3 in total

1.  Antitumor activity of bis-indole derivatives.

Authors:  Aldo Andreani; Silvia Burnelli; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Lucilla Varoli; Laura Landi; Cecilia Prata; Michael V Berridge; Carole Grasso; Heinz-Herbert Fiebig; Gerhard Kelter; Angelika M Burger; Mark W Kunkel
Journal:  J Med Chem       Date:  2008-07-04       Impact factor: 7.446

2.  Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy.

Authors:  Brian D Peyser; Ann Hermone; Joseph M Salamoun; James C Burnett; Melinda G Hollingshead; Connor F McGrath; Rick Gussio; Peter Wipf
Journal:  Mol Cancer Ther       Date:  2019-07-24       Impact factor: 6.261

Review 3.  Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer.

Authors:  Taylor P Berke; Simon H Slight; Salman M Hyder
Journal:  Onco Targets Ther       Date:  2022-01-08       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.